chemical and vaccine manufacturing
NDAA for Fiscal Year 2023 - provisions related to biological and chemical defense and access to naloxone; HR 2617 - Consolidated Appropriations Act, 2023 (Omnibus); HR 1437 - Further Continuing Appropriations and Extensions Act; Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines; Issues related to the development, manufacture, and distribution of coronavirus vaccines
DIS - Disaster Planning/Emergencies
201 - Homeland Security, Dept of (DHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
ERVIN GRAVES STRATEGY GROUP, LLC
410 1st Street, SE, Suite 300, Washington, DC, 20003, US
JAMES L ERVIN